---
company: Earth Science Tech, Inc.
ticker: ETST
form: 8-K
filed: 2026-06-18
accession: 0001493152-26-029200
source: https://www.sec.gov/Archives/edgar/data/1538495/000149315226029200/
---

# Earth Science Tech (ETST) earnings release, June 18, 2026

Earth Science Tech, Inc. (ETST) · Form 8-K, Item 2.02 · Filed 2026-06-18 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1538495/000149315226029200/)

Exhibit

99.1

Earth

Science Tech, Inc. Reports Fiscal Year-End Financial Results for March 31, 2026

MIAMI,

June 18, 2026 (GLOBE NEWSWIRE) — Earth Science Tech, Inc.

(OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential operating businesses, today announced its financial results for the full fiscal year ended March 31, 2026.

“Our fiscal 2026 results reflect the meaningful progress we have made over the last several years to build a business that is durable, self-sustaining and positioned for long-term growth,” said Giorgio R. Saumat, CEO and Chairman of the Board of Earth Science Tech, Inc. “In fiscal 2026, we grew revenue, increased earnings, generated positive operating cash flow and strengthened our balance sheet, all while not adding debt to our balance sheet. These results are driven by the work we have done to better integrate the patient experience across our platform, from telemedicine to pharmacy to fulfillment. By owning more of that process, we serve patients effectively while building a stronger and more profitable business.”

Mr.

Saumat continued, “We delivered these results while remaining disciplined with our capital. During fiscal 2026 and subsequent to year end, we repurchased and retired more than 7.1 million shares of common stock, continued investing in new products and expanded the reach of our healthcare platform.

We believe we are still in the early stages of what this business can become. Fiscal year-end 2026 laid the essential foundation for what management foresees as our next leg of growth, and this trajectory is already showing in fiscal

Q1 2027. By continuing our aggressive share buyback program—purchasing over 3.1 million shares in the first quarter of fiscal 2027 alone—we are actively creating lasting value for our shareholders. The upcoming report for the quarter ending June 30, 2026, will clearly show how the foundation laid out during fiscal 2026 is transpiring and moving forward. We remain focused on executing the same strategy that has brought us to this point by growing responsibly and investing for the future.”

For the fiscal year ended March 31, 2026, the Company reported the following results

:

About

Earth Science Tech, Inc. (ETST)

Earth

Science Tech, Inc. operates as a diversified holding company focused on the health and wellness sector. The Company’s principal operating strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The Company’s healthcare operations are supported by investments in real estate and asset management activities and a consumer products business.

The core of the Company’s value proposition is the seamless integration of patient care, from consultation to fulfillment. This is achieved through the synergy of specialized subsidiaries.

To learn more, please visit: www.EarthScienceTech.com

Forward-Looking

Statements

Except for historical information, the matters discussed herein may be considered “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.

Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including, without limitation, future-oriented statements related to cash flow, gross margins, revenues, and expenses. These statements are based on and reflect our current expectations, estimates, assumptions and/or projections, our perception of historical trends and current conditions, as well as other factors that we believe are appropriate and reasonable under the circumstances. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts. They may include forward-looking words such as “expect,” “expectation,” “believe,” “anticipate,” “may,” “could,”

“intend,” “belief,” “plan,” “estimate,” “target,” “predict,”

“likely,” “seek,” “project,” “model,” “ongoing,” “will,” “should,”

“forecast,” “outlook” or similar terminology. Forward-looking statements are subject to a number of risks and uncertainties that may cause the Company’s actual results to differ materially from our intent, belief or current expectations, including, inter alia, the markets for the Company’s products and services, costs of goods and services, other expenses, government regulations, litigations, and general business conditions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.

Company

Contact:

Giorgio

R. Saumat

CEO and Chairman of the Board

(305)

724-5684

IR@earthsciencetech.com — Tables Follow – Earth

Science Tech, Inc. and Subsidiaries

Consolidated

Balance Sheets as of March 31, 2026, and 2025

The accompanying notes are an integral part of these consolidated financial statements.

Earth

Science Tech, Inc. and Subsidiaries

Consolidated

Statements of Operations

For

Years Ended March 31, 2026, and 2025

The accompanying notes are an integral part of these consolidated financial statements.

## Financial statements

### Income Statement (For Years Ended March 31, 2026, and 2025)

| | 2026 | 2025 |
|---|---:|---:|
| Revenue | 35,695,614 | 33,117,624 |
| Cost of Goods Sold | 10,207,557 | 8,817,488 |
| Gross Profit | 25,488,057 | 24,300,136 |
| Expenses | Salaries Expense | 13,776,033 | 14,115,643 |
| Expenses | Selling general and administrative expenses | 3,571,448 | 4,154,838 |
| Expenses | Bank charges | 1,006,026 | 1,066,577 |
| Expenses | Advertising & marketing | 2,840,553 | 836,860 |
| Expenses | Legal and professional fees | 221,179 | 305,932 |
| Expenses | Insurance | 168,353 | 180,281 |
| Expenses | Operating lease cost | 180,753 | 98,434 |
| Expenses | Depreciation and amortization | 284,396 | 53,951 |
| Expenses | Utilities | 130,790 | 39,661 |
| Expenses | Total Expenses | 22,179,531 | 20,852,178 |
| Other income (expense) | Dividend and interest income | 15,458 | 9,141 |
| Other income (expense) | Net realized gain on sale of investments | 671,528 | 300,162 |
| Other income (expense) | Unrealized Gain (Loss) on fair value changes of investments | -957,118 | -365,661 |
| Other income (expense) | Other | 67,194 |  |
| Other income (expense) | Interest Expense | -16,327 | -21,189 |
| Other income (expense) | Net Income before taxes | 3,089,261 | 3,370,411 |
| Other income (expense) | Income Taxes | -511,676 | 116,776 |
| Other income (expense) | Net Income | 3,600,937 | 3,253,635 |
| Other income (expense) | Net Income/(Loss) attributed to non-controlling interest | -29,839 |  |
| Other income (expense) | Net Income available to common stockholders’ | 3,630,776 | 3,253,635 |
| Other income (expense) | Earnings per common share-Basic and Diluted | 0.012 | 0.011 |
| Other income (expense) | Weighted average number of shares outstanding- Basic and Diluted | 293,069,803 | 303,521,458 |

### Balance Sheet (As of March 31, — as of March 31, 2026, and 2025)

| | As of March 31, – 2026 | As of March 31, – 2025 |
|---|---:|---:|
| Current Assets | Cash and cash equivalents | 796,797 | 1,473,228 |
| Current Assets | Accounts receivable, net | 356,054 | 129,064 |
| Current Assets | Equity securities | 1,360,040 | 645,438 |
| Current Assets | Inventory | 682,059 | 503,938 |
| Current Assets | Long lived assets, available for sale | 371,684 |  |
| Current Assets | Prepaid Expenses and other current assets | 154,480 | 358,837 |
| Current Assets | Total Current Assets | 3,721,114 | 3,110,505 |
| Non-Current Assets | Property and Equipment, net | 1,517,888 | 1,384,110 |
| Non-Current Assets | Right of use assets, net | 95,317 | 172,429 |
| Non-Current Assets | Intangible assets, net | 208,170 | 96,885 |
| Non-Current Assets | Deferred tax asset, net | 772,294 |  |
| Non-Current Assets | Goodwill | 2,654,554 | 2,302,792 |
| Non-Current Assets | TOTAL ASSETS | 8,969,337 | 7,066,721 |
| Current Liabilities | Accounts payable | 681,925 | 492,352 |
| Current Liabilities | Accrued expenses and other payables | 1,150,442 | 2,322,022 |
| Current Liabilities | Current portion of operating lease obligations | 96,206 | 121,851 |
| Current Liabilities | Current portion of loans & obligations |  | 30,592 |
| Current Liabilities | Short-term business loans |  | 179,488 |
| Current Liabilities | Total Current Liabilities | 1,928,573 | 3,146,305 |
| Long-Term Liabilities | Lease Liability |  | 37,878 |
| Long-Term Liabilities | Loans and Obligations |  | 31,427 |
| Long-Term Liabilities | Total Liabilities | 1,928,573 | 3,215,610 |
| Stockholders’ Equity | Preferred stock, par value $0.001 per share, 1,000,000 shares authorized; 1,000,000 and 1,000,000 shares issued and outstanding as of March 31, 2026, and March 31, 2025, respectively | 1,000 | 1,000 |
| Stockholders’ Equity | Common stock, par value $0.001 per share, 300,000,000 shares authorized; 291,324,607 shares issued and outstanding as of March 31, 2026, and 295,347,903 issued and 294,302,607 outstanding as of March 31, 2025 | 291,324 | 295,348 |
| Stockholders’ Equity | Additional Paid in Capital | 30,826,352 | 31,480,143 |
| Stockholders’ Equity | Accumulated Deficit | -24,108,199 | -27,738,975 |
| Stockholders’ Equity | Treasury Stock, at cost (0 and 1,045,296 shares as of March 31, 2026, and March 31, 2025, respectively) |  | -186,405 |
| Stockholders’ Equity | Total Stockholders’ Equity | 7,010,477 | 3,851,111 |
| Stockholders’ Equity | Non-Controlling Interest | 30,287 |  |
| Stockholders’ Equity | Total Equity | 7,040,764 | 3,851,111 |
| Stockholders’ Equity | TOTAL LIABILITIES AND EQUITY | 8,969,337 | 7,066,721 |
